TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Aspire Biopharma Holdings ( (ASBP) ) is now available.
Aspire Biopharma Holdings, Inc. received notifications from Nasdaq on April 16, 2025, regarding noncompliance with listing rules due to its market value and bid price falling below required levels for 30 consecutive days. The company failed to rectify these deficiencies within the given 180-day compliance period, leading to a potential delisting notice on October 15, 2025. Aspire Biopharma has requested a hearing to present its compliance plan and seek an extension, although there is no guarantee of success.
More about Aspire Biopharma Holdings
Aspire Biopharma Holdings, Inc. operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies.
Average Trading Volume: 21,977,383
Technical Sentiment Signal: Sell
Current Market Cap: $15.82M
Find detailed analytics on ASBP stock on TipRanks’ Stock Analysis page.